Privium Fund Management B.V.
Source: SEC Form 13F · as of Mar 2026Privium Fund Management B.V. holds 20 biotech & pharma companies tracked by BioSniper, totaling $115.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$115.4M
BioSniper AIPage context preserved
Prepared research question
What matters most for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 366,936 | $23.0M |
| IONSIONIS PHARMACEUTICALS INC | 290,024 | $21.8M |
| AXSMAxsome Therapeutics, Inc. | 58,729 | $9.9M |
| ESPREsperion Therapeutics, Inc. | 3,299,441 | $9.0M |
| PRQRProQR Therapeutics N.V. | 5,467,149 | $8.9M |
| QUREuniQure N.V. | 486,520 | $8.0M |
| ARQTArcutis Biotherapeutics, Inc. | 320,972 | $7.6M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 92,305 | $5.2M |
| DNLIDenali Therapeutics Inc. | 254,857 | $4.9M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 12,222 | $4.0M |
| VRDNViridian Therapeutics, Inc.\DE | 173,516 | $3.4M |
| STOKStoke Therapeutics, Inc. | 50,000 | $1.6M |
| FDMT4D Molecular Therapeutics, Inc. | 170,256 | $1.6M |
| BEAMBeam Therapeutics Inc. | 63,982 | $1.5M |
| MRNAModerna, Inc. | 29,994 | $1.5M |
| RNACCartesian Therapeutics, Inc. | 179,114 | $1.1M |
| RCKTRocket Pharmaceuticals Inc. | 242,146 | $867K |
| AUTLAutolus Therapeutics plc | 363,430 | $502K |
| FATEFATE THERAPEUTICS INC | 414,311 | $497K |
| VYGRVoyager Therapeutics, Inc. | 120,000 | $463K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.